Lallemand Health Solutions gains new Canadian claims showing its probiotics can help formula-fed babies develop a similar microflora as to breast-fed ones

For the first time a health authority recognizes that probiotics, particularly Lallemand Health Solutions strains Bifidobacteria infantis Rosell®-33, and Bifidobacteria bifidum Rosell®-71,…

Lallemand Health Solutions celebrates its know-how and its growth in good company

Lallemand Health Solutions inaugurated its ultra-modern probiotic bacteria production plant, Harmonium II, with elected officials from the Mirabel region, Ms. Sylvie D’Amours,…

Having IMPACTT 2022: The Rosell® Institute for Microbiome and Probiotics Renews Its Platinum Sponsorship

The Rosell® Institute for Microbiome and Probiotics by Lallemand reconducts its platinum sponsorship of the Canadian microbiome symposium, Having IMPACTT, for a…

Lallemand Health Solutions: Gold Sponsor of Probiota Americas

As Gold Sponsor, Lallemand Health Solutions is supporting the IPA World Congress + Probiota Americas, presented by NUTRAIngredients-USA.com. This major annual event…

Lallemand Health Solutions Opens the SEMiPyP Congress With An Update on IBacilluS+: A Highly Documented Probiotic Formula for Serious Gut Conditions

Sara Caballero Calero, M.Sc. Clinical Research Specialist at the Rosell® Institute from Microbiome and Probiotics by Lallemand, will be the guest speaker…

Innovative Health Claims Approved by Authorities Confirms Benefits of L. rhamnosus HA-114 to Support Weight Management Efforts

Lallemand Health Solutions has gained innovative indications for its probiotic strain L. rhamnosus HA-114 from Health Canada, recognizing its beneficial impact to…

Vitafoods Europe 2022: All Lights on Metabolic, Women’s, Mental and Gut Health

Lallemand Health Solutions’ team has some amazing novelties to tell you about at Vitafoods Europe in Geneva Palexpo, Switzerland from May 10-12,…

Live presentation about a unique three-strain synbiotic to support immune health at SupplySide® Sponsored Intensive, April 20, 2022

Join in to watch Lucie Lingrand, Product Manager at Lallemand Health Solutions live presentation about a unique three-strain synbiotic to support immune…

Lallemand Health Solutions at Pharmabiotics: Join in To Learn More About Discovery, Development & Preclinical Research

Annie Tremblay, Scientific Writer at Lallemand Health Solutions will present Preclinical and Clinical Studies Shed Light on Potential Modes of Action of…

NEW Approved Canadian Claim: L. paracasei HA-196 Helps Support Healthy Bowel Habits in Adults With IBS

Lallemand Health Solutions has gained new indication for its probiotic strain L. paracasei HA-196 from Health Canada recognizing its beneficial effects to…